Investor Relations
Investor Relations
Myrexis, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.
Recent Releases
Sep 2, 2010
Aug 31, 2010 Events & Presentations
Sep 9, 2010 at 4:30 PM ET |
|
||||||||||||||||||||||



